-
Mashup Score: 1Racial disparities in cardiotoxicity after chemotherapy - 1 year(s) ago
“The most important message is to look at preexisting cardiovascular disease, oncology diagnosis, and be aware of existing disparities in a specific cancer and CVD.”
Source: www.mdedge.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Study Explores Genomic Basis of Racial Disparities Among Patients With Colorectal Cancer - The ASCO Post - 1 year(s) ago
By Jo Cavallo Posted: 4/18/2023 10:44:00 AM Last Updated: 4/18/2023 12:19:55 PM Black individuals are disproportionately affected by colorectal cancer. They have the highest rates of the disease of any racial or ethnic group in the United States, and are about 20% more likely to develop colorectal cancer and…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0No racial disparities observed in chronic HBV treatment rates among eligible patients - 1 year(s) ago
Although Black individuals with chronic hepatitis B were less likely to meet treatment criteria, researchers reported no significant differences in treatment initiation between racial groups, according to data in JAMA Network Open.“Because Asians and Blacks have higher prevalence of chronic HBV infection and are more likely to develop liver cancer, we examined whether there are racial
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0
“It tells you that when two groups of people with different ancestry get the same treatment for the same subtype of cancer, they have a different response.”
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Drs Dellavalle and Rodriguez Discuss Disparities in Prescription Patterns for Atopic Dermatitis - 1 year(s) ago
Using the DataDerm database has uncovered disparities in prescription patterns, but it’s still early in the process of understanding why those disparities might exist, said Robert Dellavalle, MD, PhD, MSPH, and Ramiro Rodriguez, MD, both of University of Colorado School of Medicine.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0
Clinical trials are essential to progress in medicine, but racial and ethnic minorities are frequently underrepresented in such studies. In this ASCO Education podcast episode, we will examine this issue with Dr. Carol Brown, gynecologic cancer surgeon and Chief Health Equity Officer at Memorial Sloan Kettering Cancer Center, Dr. Ana Maria Lopez, Professor and Vice Chair of Medical Oncology at…
Source: auwpod.libsyn.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Advancing More Equitable Care Through the Development of a Health Equity Report Card - 1 year(s) ago
The root causes of racial disparities in access to optimal cancer care and related cancer outcomes are complex, multifactorial, and not rooted in biology. Contributing factors to racial disparities in care delivery include implicit and explicit bias, lack of representation of people of color in the oncology care and research workforce, and homogenous research participants that are not…
Source: JNCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0New Data Show Severe Maternal Morbidity is a Threat to People with Sickle Cell Disease - 1 year(s) ago
“Despite advances in SCD management and high-risk pregnancy care, at the national level, outcomes in this population have not improved since the last NIS analysis of data from 1999 to 2008,” investigators write.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet
#RacialDisparities in #Cardiotoxicity after #Chemotherapy 👉https://t.co/IiEFzTIg8r @MDedgeHemOnc #Cardiooncology https://t.co/t5yPwpv9Ak